Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection.

ABSTRACT: Persistent severe acute respiratory syndrome coronavirus 2 infection is difficult to treat. Here, we report a case of 5-month persistent coronavirus disease 2019 in an immunocompromised patient who was successfully treated with 30 consecutive days of remdesivir. Prolonged remdesivir infusion with concurrent cycle threshold monitoring might provide a potential solution to cure these patients with difficult-to-treat infections.

SUBMITTER: Martinez MA 

PROVIDER: S-EPMC9384609 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature